The Food and Drug Administration has approved the first treatment that gives limited sight to people blinded by a certain hereditary disease.
The device, called the Argus II Retinal Prosthesis System, allows visual signals to bypass the damaged portion of the eye and be directly transported to the brain.
Patients have a sheet of electrodes implanted in their eye, and wear a pair of glasses with a video processor and a camera.
The device is only available for patients who have retinitis pigmentosa, a genetic condition in which the retina – the part of the eye that converts light images into signals that can be received by the brain – deteriorates.
Second Sight Medical Products, the company that makes the Argus II, told The New York Times its hopes to eventually address all forms of blindness through electrode implantation in various parts of the brain.
Kathy Blake, who was diagnosed with retinitis pigmentosa in her early 20s, participated in the studies of the Argus II and had the device installed a few years ago.
Blake told Here & Now that even though the sight she regained is limited, she’s very appreciative.
“This is a huge welcome advance for me,” she said. “I often talk about being able to see the fireworks a few years ago. I could look up in the sky and see all the flashes.”
Jeremy Hobson joins Robin Young as co-host of Here & Now in its new 2-hour format, from WBUR and NPR.
The organizers of the Boston Marathon have issued special invitations to 450 people who made the case they were profoundly affected by the bombings in April.2 Comments | more »
Almost a year after 20 children and six educators were killed at Sandy Hook Elementary School, some states have toughened gun rules, while others have loosened them.130 Comments | more »
As the BBC’s State Department correspondent, Kim Ghattas has traveled hundreds of thousands of miles with U.S. secretaries of state, including Condoleezza Rice, Hillary Clinton and John Kerry.1 Comment | more »